Pedaling away chemo pain: new study tests cycling as a remedy for nerve damage
NCT ID NCT07150117
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether a 12-week supervised cycling program can reduce nerve pain and improve quality of life in 30 adults who have had chemotherapy for cancer. Participants will ride a stationary bike twice a week for up to an hour. The main goal is to see if people find the program acceptable and if a larger trial is worth doing.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
supervised stationary cycling exercise program
What this could lead to
If it works, this could point toward a simple, drug-free way to reduce nerve pain and improve daily function for cancer survivors.
What could go wrong
This is a very small, early proof-of-concept study with only 30 people. It is designed to see if a larger trial is even possible, not to prove the exercise works. Results may not apply to everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cross Cancer Institute
RECRUITINGEdmonton, Alberta, T6G 1Z2, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••